Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies

Mika Asai-Coakwell1, Lindsey March, Xiao Hua Dai

  • 1Department of Ophthalmology, University of Alberta, Edmonton, AB, Canada.

Human Molecular Genetics
|January 12, 2013
PubMed

Insights

Mutations in Growth Differentiation Factor 6 (GDF6) cause Leber congenital amaurosis and photoreceptor degeneration. A novel compound, P7C3, rescued retinal apoptosis in zebrafish models, suggesting new therapeutic avenues for retinal dystrophies.

Area of Science:

  • Genetics
  • Developmental Biology
  • Ophthalmology

Background:

  • Retinal dystrophies often stem from mutations impacting the phototransduction system and cilia.
  • Identifying genes crucial for photoreceptor survival is vital for understanding and treating these conditions.

Purpose of the Study:

  • To investigate the role of early embryonic retinal development growth factors in retinal dystrophies.
  • To determine if mutations in Growth Differentiation Factor 6 (GDF6) are linked to Leber congenital amaurosis and photoreceptor degeneration.

Main Methods:

  • Analysis of mutations in GDF6, a transforming growth factor-β (TGF-β) ligand.
  • Utilizing murine and zebrafish mutant models to study gdf6 deficiency.
  • Assessing the effect of P7C3, a novel compound, on retinal apoptosis in gdf6-deficient zebrafish.

Main Results:

  • Mutations in GDF6 were identified as contributors to Leber congenital amaurosis.
  • gdf6 deficiency led to photoreceptor degeneration and retinal apoptosis in animal models.
  • Treatment with P7C3 successfully rescued retinal apoptosis in zebrafish without toxicity.

Conclusions:

  • Perturbed TGF-β signaling, specifically involving GDF6, is implicated in the development of retinal dystrophies.
  • GDF6 plays a role in photoreceptor survival.
  • These findings suggest GDF6 and related morphogenetic genes as targets for retinal disease and offer potential therapeutic strategies beyond gene therapy.